A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects

Phase 1/2 Active not recruiting 74 enrolled Shandong Suncadia Medicine Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of HRS-7535 tablet in obese subjects.

Timeline

Start: 2024-10-30
Primary completion: 2025-05-30
Completion: 2025-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-7535	Small molecule	—	—

A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects

Summary

Timeline

Drugs

Indications